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Xanthine oxidoreductase (XOR) is the rate-limiting enzyme in purine catabolism occurring in most cell types. 
However, this housekeeping gene is expressed at very high levels in a number of mammalian tissues including 
the lactating mammary epithelium, suggesting additional roles lor XOR  in these tissues. Mice with targeted 
disruption of XOR  were generated to assess these potential additional roles. X O R -/- mice are runted and do 
not live beyond 6 wk of age. Strikingly, however, XOR+/- females, although of healthy appearance and normal 
fertility, are unable to maintain lactation and their pups die of starvation 2 wk postpartum. Histological and 
whole-mount analyses showed that in XOR+/- females the mammary epithelium collapses, resulting in 
premature involution of the mammary gland. Electron microscopy showed that XOR is specifically required 
for enveloping milk fat droplets with the apical plasma membrane prior to secretion from the lactating 
mammary gland. We present evidence that XOR may have primarily a structural role, as a 
membrane-associated protein, in milk fat droplet secretion and thus XOR  provides another example of "gene 
sharing". About 5% of women experience primary lactation insufficiency. The above observations suggest that 
human females suffering from xanthinuria, a deficiency in XOR, are potential candidates for lactation 
problems.
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Xanthine oxidoreductase (XO.R) is a housekeeping gene 
that encodes a molybdenum iron-sulfur flavin hydroxy­
lase found in all organisms. In vitro experiments show 
that XOR is a relatively nonspecific, multifunctional en­
zyme, capable of oxidizing a variety of substrates includ­
ing purines, pyridine dinuclcotidcs, ptcridincs, and alde­
hydes. Although it is one of the best studied enzymes in 
vitro, the complexities of its in vivo functions arc less 
well understood. In vertebrates, a primary role of XOR is 
its participation in purine catabolism. The holo-cnzymc 
exists as a homodimcr and is composed of two identical 
and catalytically independent subunits, each containing 
two [2Fc-2S] groups, one FAD, and one molybdoptcrin 
(Rajagopalan and Handler 1967; Massey ct al. 1969; Bray 
ct al. 1975; Carpani ct al. 1990; Cazzaniga ct al. 1994; 
Hillc and Nishino 1995).
XOR can be isolated as two distinct enzymatic forms 
from most biological sources: either as xanthine dehy­
drogenase (XD; EC 1.1.1.204) or as xanthine oxidase (XO;
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EC 1.1.3.22). The mammalian XD and XO forms arc in­
terconvertible in vitro (Waud and Rajagopalan 1976; 
Amaya ct al. 1990). XD is the predominant enzymatic 
form found in normal tissues, while the XO form domi­
nates in tissues subjected to injury. The different struc­
tural and catalytic activities as well as the preference for 
different oxidation substrates is derived from an addi­
tional NAD+ binding site in XD. Hence, with XD, the 
reducing equivalents generated by the oxidation of sub­
strates arc transferred to NAD+, whereas XO is unable to 
bind NAD+ and exclusively uses 0 2 as its electron ac­
ceptor. The latter reaction results in the production of 
reactive oxygen species (ROS) as a metabolic byproduct. 
ROS arc produced excessively under certain pathophysi­
ological conditions and, for this reason, the conversion of 
XD to XO is of major medical interest. XO has been 
implicated in many diseases associated with oxygcn- 
radical-induccd tissue damage, contributing to post- 
ischemic rcpcrfusion injuries, as well as aging (Fridovich 
1970; Parks and Granger 1983; McCord 1985; Granger ct 
al. 1986; Engcrson ct al. 1987; Chung ct al. 1999).
Besides its role as a housekeeping gene, XOR  is highly 
expressed in liver and kidney, the main organs involved
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in purine catabolism and nitrogen elimination. Further­
more, it is found at high levels in a number of other 
mammalian tissues and organs, including the mammary 
gland (Jarasch ct al. 1981; Kurosaki ct al. 1995, 1996). 
This suggests that XOR plays additional roles in these 
tissues beyond its metabolic function(s). In humans, de- 
ficicncics of the enzyme arc known to result in xanthi­
nuria, an autosomal-rcccssivc disorder leading to kidney 
stone formation, urinary tract disorders, and musclc dis­
eases (Dent and Philport 1954). However, no other his­
tological or physiological symptoms have been associ­
ated with rcduccd activity of XOR.
It has long been known that cow milk contains high 
levels of XOR activity. Expression of XOR  in the lactat- 
ing mammary gland is rcstrictcd to the sccrctory epithe­
lium. In vitro analyses show that the transcription, 
translation, and cnzymatic activity of XOR arc up-rcgu- 
latcd during late prcgnancy and throughout lactation. 
XOR has therefore been used as a marker for terminal 
differentiation of mammary epithelial cclls. Interest­
ingly, XOR expression levels positively correlate with 
the sccrctory activity of the mammary epithelial cclls. 
Furthermore, XOR expression is highly induccd by lac- 
togcnic hormones (Schardingcr 1902; Massey ct al. 1969; 
Hayden ct al. 1991; Abadch ct al. 1992; Hunt and Massey 
1992; Linder ct al. 1999; McManaman ct al. 1999, 2000). 
These observations support the idea that XOR has a spe­
cific role in the mammary gland during lactation. By 
generating micc containing a targeted disruption in 
XOR, it has been possible to study this role. Wc demon­
strate that female micc heterozygous for a XOR  loss-of- 
function mutation arc unable to maintain lactation due 
to failure to sccrctc fat droplets into the milk.
Results
Generation of mice deficient for XOR
XOR is the product of a single gene containing 36 exons. 
Using homologous recombination in cmbryonic stem 
(ES) cclls (Capecchi 1989) micc carrying a null mutation 
for XOR were generated by inserting, in frame, the Green 
Fluorescent Protein {GFP) gene and a loxP/tACE-Cre/  
neo'/loxP-casscttc into the third exon of XOR  (Fig. 1A). 
The mutant XOR  gene produces a truncated protein 
composed of exons 1, 2, and a portion of exon 3 fused to 
GFP. The Cre/neor casscttc in the mutant XOR  allele is 
automatically cxciscd from the locus in sperm produced 
by the chimcric animals that were generated from these 
ES cclls (Bunting ct al. 1999).
Pups from  XOR+/- females die at approximately 12 
days postpartum
Micc homozygous (-/-) for the mutation in XOR  arc 
runted and do not live beyond 6 wk of age. XOR  hetero­
zygous (+/-) micc arc viable and show normal fertility, 
litter size, and maternal behavior. However, all pups 
fromXOR+/- females, regardless of genotype, die around 
day 12 postpartum (P12) of malnourishmcnt. In contrast 
to controls, disscctcd pups born to these females were
Figure 1. Targeting strategy for disruption of the XOR gene 
and pathology of pups raised by XOR+/- mothers. (A) A cassette 
containing pGFP/1oxP/tACE-Cre/neor/1oxP was inserted into 
the Hindlll restriction site of the third exon of XOR genomic 
sequence, creating a loss-of-function mutation. Exons are 
shown as boxes and identified numerically. (/>-£) Pups of wild- 
type (WT) and XOR+I- mothers at PI2. Pups from XOR+I- 
mothers do not have the body fat stores of brown fat (C) and 
mammary fat pads (£) that age-matched pups from wild-type 
mothers have bf, brown fat; mfp, mammary fat pad; s,
scapula. (F) Average body weight increase of pups nursed by 
wild-type (WT) and XOR+I- mice. Pups of XOR+I- mothers 
start to die at lactation day 12. Each data point represents the 
average of 3 litters each with 6 pups (n = 18). Data are 
means ± S.D. Magnification: H,C, 2.5x; D,E, 4x.
found to be devoid of adipose tissue, such as brown fat 
and mammary fat pads (Fig. 1B-E). In addition, skeletal 
musclcs were rcduccd in volume, consistent with star­
vation (data not shown). The bladders of the pups from 
XOR+I- mothers were normal and filled with urine (data 
not shown), indicating that dehydration was not the 
causc of death. To further analyze this process, the body 
weight of litters nursed by either wild-type or XOR+I- 
micc was monitored between birth and P13 (Fig. IF). 
Until P4, the average body weight of the pups nursed by 
XOR+I- mothers was not significantly different from 
control pups. Pups nursed by XOR+I- mothers began to 
appear visibly malnourished by P6. By P12, when pups 
from the mutant mothers begin to die, the pups were 
emaciated, and by P13, the remaining pups showed less
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than 50% of the body weight of the control litter. Fos­
tering experiments showed that pups from XOR+/- mice 
can be raised normally by wild-type mothers (data not 
shown).
Mammary glands of XOR+/- mice undergo tissue 
destruction during lactation
The development of the mammary glands in wild-type 
and XOR+/- mice was examined in H&E stained paraffin 
sections and whole-mount preparations during late preg­
nancy and throughout lactation. No differences were 
found during pregnancy (data not shown) or at lactation 
day 1. The development of epithelial lobular-alveolar 
structure and the amount of adipocyte tissue appeared to 
be the same in wild-type and XOR+/- mammary glands 
on this day (Fig. 2A,B,IJ). By lactation day 5, the mam­
mary epithelium of wild-type and XOR+/- glands prolif­
erated and showed many expanded alveoli, indicating ac­
tive milk secretion (Fig. 2C,D,K,L). The epithelium from
XOR+/- mammary glands appeared similar,- however, 
more adipocytes, which shrink in volume to provide 
fatty acids for milk fat synthesis, were still visible (Fig. 
2D). In addition, within numerous mammary alveoli of 
the XOR+/- mice cell blcbbing was detected; some of 
those cytoplasmic fragments were associated with milk 
fat droplets (Fig. 2D,L, arrows). At lactation day 11, the 
wild-type mammary alveoli expanded further, correlat­
ing with increased milk synthesis, secretion, and pup 
size (Fig. 2E,M). The XOR+/- mammary epithelium, 
however, showed severe cell shedding and tissue frag­
mentation associated with loss of epithelial tissue vol­
ume and premature tissue involution (Fig. 2F,N). By lac­
tation day 13, severe tissue remodeling in the XOR+/- 
mammary epithelium resulted in the collapse of many 
mammary alveoli and less epithelial tissue remained 
throughout the mammary gland (Fig. 2H,P). The major­
ity of the epithelial tissue appeared to be lactation defi­
cient. However, some of the alveoli still seemed cx-
Figure 2. Histological analysis of normal and X O R + /-  mammary glands. [A-P] Paraffin sections of mammary glands taken at various 
times during lactation and stained widi hematoxylin and eosin. X O R + /-  mammary epithelium undergoes destruction within die first 
half of lactation. Glands at lactation days 1 ( ) ,  5 [C,D,K,L), 11 (E,F,M,N), and 13 (G,H,0,P). WT mammary glands are shown in 
A,C,E,G,I,K,M,0. X O R + /-  mammary glands are shown in B,D,F,HJ,L,N,P. Magnification, 125x and 500x.
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pandcd due to milk sccrction and many of the mammary 
epithelial cclls still contained fat droplets, indicating 
that mammary tissue destruction was independent of a 
dcfcct in lactogcnic hormones. Overall, tissue damage in 
the XOR+f- mammary gland correlates with the time 
coursc of pup starvation. An analysis of whole-mount 
preparations of wild-type and XOR+f- mammary glands 
at lactation day 13 revealed again the overall collapsc of 
the XOR+f- epithelial tissue (Fig. 3A,B). However, only 
the sccrctory portion of the gland, the milk sccrcting
alveoli, were affcctcd, while the ducts, which mainly 
transport the sccrctions to the exterior of the gland, ap­
peared normal (Fig. 3B, red arrows).
The enzymatic activity of XOR is reduced 
in terminally differentiated XOR+/- mammary glands
Previous studies have shown that the cnzymatic activity 
and expression level of XOR increase during late preg­
nancy and remain high throughout lactation (Kurosaki ct
Figure 3. Whole-mount analysis and XOR enzymatic activity of wild-type and XOR+f-  mammary glands. {A,B) Whole-mount 
analysis of wild-type (WT, A ) andXOR+/- (B) mammary glands at lactation day 13. The milk-secreting alveoli are collapsed in XOR+f - 
mammary glands compared to wild-type, while the ducts are unaffected (red arrows). Tissue was stained with indigo carmine alum. 
(C) Reduced XOR enzymatic activity in terminally differentiated XOR+f-  mammary glands. XOR activity in mammary glands of 
wild-type (WT) and XOR+f- mice was measured during late pregnancy (P) and early lactation (Lac). XOR activity is expressed as 
micromolar of isoxantho-pterin formed/minutes per milligrams of total mammary gland protein. Each value is the mean ± S.D. of eight 
separate tissue extracts. Magnification: A,B, 31.25x.
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al. 1996; McManaman ct al. 1999). To determine 
whether the absence of one allele of XOR results in re­
duced enzymatic activity of XOR in the mammary 
gland, the level of XOR activity was determined at mul­
tiple time points throughout late pregnancy and early 
lactation. At pregnancy day 15, wild-type and XOR+j- 
mammary glands showed similar levels of enzymatic ac­
tivity (Fig. 3C). During later pregnancy, XOR activity 
was increased in accordance with earlier reported analy­
ses. However, enzymatic activity increased less in 
XOR+/- mammary glands than in wild-type glands. In 
addition, while XOR activity remained high in the wild- 
type mammary glands throughout lactation, the enzy­
matic activity in XOR+j- glands steadily decreased post­
partum, which correlates with the destruction of lactat- 
ing mammary epithelium in the XOR+j- mice. 
Additional analyses of XOR activity in various organs of 
XOR+j- mice showed that the enzymatic activity of 
XOR is about 50% less than in wild-type tissue (A.f. 
Scrivcn and M.R. Capecchi, in prep.).
Milk fat droplets accumulate in the mammary 
epithelium  o/XOR+/- mice
Toluidinc blue stained semithin sections showed that 
already by lactation day 1, milk secretion was perturbed 
in XOR+j- mice. Most fat droplets in wild-type mam­
mary glands were secreted and accumulated in the lu­
men of the alveoli (Fig. 4A). Only a few wild-type epi­
thelial cells contained cytoplasmic fat droplets. How­
ever, in the XOR+j-  mammary gland, secretion of milk 
fat droplets was perturbed and cytoplasmic fat droplets 
accumulated in most of the mammary epithelial cells 
(Fig. 4B). Few fat droplets were successfully secreted into 
the lumen of the XOR+j-  alveoli, although some ap­
peared to be forced out (Fig. 4B, red arrows). In addition, 
the accumulated fat droplets in the XOR+j-  epithelial 
cells were often very large, presumably due to ongoing 
fat droplet synthesis and fusion with smaller droplets. 
Still, the lumen of XOR+j-  mammary glands appeared to 
be rich in colloidal particles, known as the casein mi­
celle (Fig. 4B, dark dots in the lumen of the mammary 
gland alveoli), suggesting that protein secretion is nor­
mal and only fat droplet secretion is defective. To deter­
mine if protein secretion is altered in XOR+j-  mammary 
glands, milk protein content from XOR+j-  and wild-type 
mice was compared. Electrophoretic separation of milk 
samples from lactation days 2-6 showed no difference in 
major milk protein content (data not shown).
The accumulation of milk fat droplets in the XOR+j-  
mammary tissue was also verified following food depri­
vation. Milk fat is the major caloric supply for newborns, 
and its synthesis is very sensitive to the mother's caloric 
intake and/or body fat. Rodents have very little meta­
bolic reserve in comparison to their rate of milk synthe­
sis, and prolonged food deprivation leads to a state of 
starvation with a significant effect on the synthesis of all 
milk components (Williamson 1990). After depriving 
wild-type and XOR+j-  mice of food for about 30 h start­
ing at lactation day 1, wild-type mammary epithelium
Figure 4. Milk fat droplets accumulate in XOR+/~ mammary 
epithelium and less fat is formed in XOR+/- milk. {A,B) Histo­
logical analysis of resin-embedded mammary glands of wild­
type (WT, A) and XOR+/~ (2?) mice at lactation day 1. The red 
arrows indicate XOR+/~ epithelial cells that try to force out 
accumulated fat droplets. L, lumen of the mammary alveoli. 
(C,D) Lactating wild-type (WT) and XOR+/~ mice were milked 
for milk fat analysis. Light microscopic analysis of milk 
samples show that XOR+/~ (2?) milk contains fewer fat droplets 
than milk from wild-type (WT, A) mice. (£) Creamatocrit analy­
sis estimates 23.9% of average milk fat in WT mice, while only 
14.7% in milk of XOR+j-  mice. Values are the mean ± S.D. of 
10 separate milk samples from lactation day 2. Magnification: 
A-D, 500x
was completely depleted of fat droplets, owing to the 
absence of additional milk fat synthesis. Previously syn­
thesized milk fat droplets were secreted and some were 
still found in the lumen. However, the XOR+j-  mam­
mary epithelium still contained a significant number of 
fat droplets, again consistent with a defect in their se­
cretion (data not shown). Further analyses of milk fat 
using microscopy and creamatocrit analysis show a re­
duction of milk fat content in the XOR+j-  milk com­
pared to wild-type milk (Fig. 4C-E).
Defective enveloping of m ilk fat droplets with the apical 
epithelial plasma membrane in XOR+/- mammary glands
Most milk components arc secreted from the mammary 
epithelium by cxocytosis, while milk fat droplet sccrc-
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tion occurs by a unique mechanism. Cytoplasmic fat 
droplets arc surrounded by a monolayer derived from the 
membranes of the ER in which fat droplet synthesis 
takes placc. During the proccss of milk secretion, fat 
droplets become further enveloped by a bilaycr of phos­
pholipids derived from the apical plasma membrane 
from where they bud into the lumen of the mammary 
alveoli. To analyze the fat droplet sccrction dcfccts in 
the XOR+/- mammary gland on a subcellular level, 
transmission clcctron microscopy (TEM) was performed. 
TEM analyses of lactating mammary glands at lactation 
days 1-5 show that the mechanism of milk fat droplet 
enveloping is perturbed inXOR+/- mammary glands. In 
wild-type glands, cach fat droplet was tightly enveloped 
with the apical membrane prior to sccrction. Oncc a 
milk fat droplet was successfully sccrctcd, the bilaycr 
membrane was clearly visible around the floating fat 
droplet (Fig. 5A, arrows). In contrast, in XOR+/- mam­
mary glands, some fat droplets became severely de­
formed during the proccss of sccrction and were envel­
oped by a very abnormal membrane (Fig. 5B, black ar­
row). Figure 5C shows complete abscncc of milk fat 
droplet enveloping by the apical membrane. The entire 
fat droplet is still surrounded by cytoplasm as it was 
forccd out of the ccll (black arrow). In other eases, fat 
droplets burst while being secreted (Fig. 5D, black ar­
rows). Some fat droplets seemed to be partially envel­
oped, yet other areas showed cytoplasmic crescents (Fig. 
5E, black arrows). Incomplete enveloping by the apical 
membrane was also seen with deformation of the fat 
droplet where it remained nonenveloped (Fig. 5F).
TEM examination of lactating wild-type and XOR+/- 
mammary alveoli also showed numerous abnormal milk 
fat droplets as well as various cell fragments floating in 
the milk of lactating XOR+/- mice. Milk fat droplets 
from wild-type mammary glands were tightly enveloped 
with epithelial plasma membrane, which subsequently 
stabilizes the free-floating droplets (Fig. 5G). Numerous 
milk fat droplets inXOR+/- mammary glands contained 
cytoplasmic crescents of various sizes (Fig. 5H,I, black 
arrows). Fat droplets with cytoplasmic crescents also oc­
cur naturally in the milk of many mammalian species 
(Huston and Patton 1990) but wild-type mice showed 
very few. Furthermore, milk fat droplets with very ab­
normal surrounding membranes (Fig. 51, white arrows), 
partially enveloped milk fat droplets (Fig. 5J, white ar­
rows), burst milk fat droplets (Fig. 5J,K, black arrows), as 
well as many budded cell fragments, often containing 
secretory vesicles filled with casein micelles (Fig. 5L; 
black arrows point to cell fragments, white arrow points 
to secretory vesicle) were found in milk of XOR+/- mice.
Secreted m ilk fat droplets in early lactating XOR+/- 
mice show various membrane phenotypes
TEM analyses of milk fat droplet membranes revealed 
various membrane phenotypes in XOR+/- milk. Some 
droplets appeared correctly enveloped with the apical 
plasma bilaycr as found in wild-type (Fig. 6A, white ar­
row). Others contained the cytoplasmic fat droplet
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monolayer with unidentified associated structures (Fig. 
6A, white arrowhead). As the enlargement in Figure 6B 
shows, these rounded structures appear to be under the 
fat droplet monolayer and are not associated with this 
membrane (white arrowhead). Therefore, they are not 
likely to be secreted milk proteins. Milk fat droplets that 
did not contain any membrane at all and burst through 
the cytoplasmic fat droplet monolayer, were also ob­
served (Fig. 6A, black arrow). In some instances, different 
membrane phenotypes could be identified on a single 
XOR+/- milk fat droplet (Fig. 6C). Normal bilaycr mem­
brane (white arrow), a region with the unidentified asso­
ciated structure (white arrowhead), and a small cytoplas­
mic crescent (black arrow) were all observed together. 
Figure 6D shows a milk fat droplet that was partly en­
veloped, but as there was still some cytoplasm between 
the apical membrane and the fat droplet, the envelop­
ment was not stable and the membrane seems to be 
breaking off (arrow).
Defective enveloping of m ilk fat droplets in lactating 
XOR+/- mamm ary glands causes tissue necrosis 
and premature involution of the mamm ary epithelium
As light microscopy analyses demonstrated, the defect in 
milk fat droplet secretion in the XOR+/- mammary 
gland severely impacts the epithelial cells, causing the 
destruction of the epithelium in several ways. TEM 
analysis detected entirely destroyed mammary epithelial 
cells within secretory XOR+/- alveoli at a subcellular 
level. Figure 6E shows a section of a milk secreting 
XOR+/- alveolus with several epithelial cells that have 
deteriorated by lactation day 3 (arrows). The enlarge­
ment of burst epithelial cells in Figure 6F shows the large 
amount of mitochondria and ER membranes that are 
typical for lactating mammary epithelial cells (arrows). 
This again demonstrates on a subcellular level the tre­
mendous damage the defect in milk fat droplet envelop­
ing causes to the entire lactating mammary gland, result­
ing in tissue necrosis, premature involution of the epi­
thelium, starvation, and death of the offspring.
Discussion
A genetic functional analysis of XO R's role in mamma­
lian lactation is provided. We demonstrate that XOR is 
required in the lactating mammary gland for milk fat 
droplet enveloping with the apical epithelial plasma 
membrane and subsequent secretion via budding from 
the terminal differentiated mammary epithelium. The 
defect in milk fat droplet secretion in the XOR+/- mice 
causes the rupture of the lactating mammary epithe­
lium, resulting in premature involution of the mammary 
gland and starvation of the offspring during the second 
week of lactation.
The mechanism of milk fat droplet secretion is unique 
to the mammary epithelium. Unfortunately, the cellular 
mechanisms of fat droplet synthesis and secretion are 
still poorly understood (Keenan 2001). Fat droplet syn-
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Figure 5. The mechanism of milk fat droplet enveloping with the apical plasma membrane is disturbed in XOR+/- mammary glands. 
{A-F) TEM analysis of wild-type (WT, A) and XOR+/- (B-FJ mammary glands at lactation day 3. Defective enveloping results in several 
fat droplet secretion phenotypes in the XOR+/- mammary glands. L, lumen of the mammary gland filled with casein micelles. (G-L) 
TEM analysis of milk in mammary alveoli at lactation day 3 from wild-type (WT, G) and XOR+/~ (H-L) mammary glands. Various 
deformed fat droplets and numerous cell fragments are found in milk from XOR+/~ mice. Magnification: A-F, 6000x-10,000x; G-L, 
5000x-15,000x.
GENES & DEVELOPMENT 3229
Downloaded from www.genesdev.org on September 14, 2006
Vorbaeh e t al.
Figure 6. Various membrane defects in milk fat droplets from XOR+I- mice. (A-D) TEM analysis of milk fat droplets from XOR+I- 
mammary glands at lactation day 3. (A) The white arrow points to a bilayer membrane of correctly enveloped fat droplet areas as found 
in wild-type. The black arrow points to a completely unenveloped droplet. The white arrowhead points to an unidentified membrane 
structure discussed in the text. (/?) Higher-power view of the boxed area in A. (C) Three membrane phenotypes can be found on a single 
XOR+I- milk fat droplet. The white arrow points to a portion of normal membrane bilayer. The black arrow indicates a piece of 
cytoplasmic crescent. Another portion of the fat droplet is occupied by the unidentified membrane structure as seen in A and B (white 
arrowhead). (D) XOR+I- milk fat droplet with a portion of cytoplasmic crescent that is only loosely associated with the droplet. (£) 
TEM analysis of an entire alveolus in a XOR+I- mammary gland at lactation day 3. The arrows point to completely destroyed 
mammary epithelial cells. (F) Higher-power view of boxed area in (£). Numerous free-floating mitochondria and ER are seen in burst 
cells of XOR+I- mammary glands (white arrows). N, nucleus. Magnification: A, 30,000x; B, 70,000x; C,D, 50,000x; £, 1000x; F, 3000x.
thesis occurs dc novo in the ER from which fat droplets phospholipids and associated proteins (Ghosal ct al. 
arc released as microlipids surrounded by a monolayer of 1994). Fat droplets presumably form in the hydrophobic
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ccntcr of the ER bilayer and growth of the fat droplets 
appears to drive the opposing ER membrane monolayers 
apart, resulting in a bulge that buds into the cytoplasm 
(Long and Patton 1978; Zaczck and Keenan 1990). A 
transport system is proposed to bring the microlipid 
droplets to the apical membrane of the mammary epi­
thelial cells. Throughout this transport proccss microlip­
ids fuse to larger cytoplasmic lipid droplets (CLDs). The 
CLDs bccomc tightly enveloped with the apical plasma 
membrane and finally bud off into the lumen of mam­
mary alveoli (Mather and Keenan 1998). The present 
study demonstrates that milk fat droplet synthesis, fu­
sion, and apical transport appear to be normal in the 
lactating XOR+/- micc. Only the final step, enveloping 
the milk fat droplets with apical membrane prior to se­
cretion, is abnormal.
The molecules that mediate enveloping of milk fat 
droplets arc proteins associated with and integrated into 
the apical mammary epithelial membrane as well as the 
proteins found on CLDs. Most of these proteins arc not 
expressed in undifferentiated mammary glands. Numer­
ous milk fat globule membrane (MFGM) proteins have 
been isolated and characterized from milk fat of several 
spccics, and their subcellular orientations have been de­
termined (Mather 2000). Interestingly, XOR is the sec­
ond most common protein among the major MFGM pro­
teins, comprising as much as 13% of total proteins. It has 
been estimated that XOR concentration increases >150- 
fold in the MFGM over its levels in the cytoplasm. While 
several of the MFGM proteins arc integral transmem­
brane proteins, XOR is a globular cytoplasmic protein 
tightly associated with the membrane (Jarasch ct al. 
1977; Mangino and Brunner 1977; Frcudcnstcin ct al. 
1979; Frankc ct al. 1981; Mather ct al. 1982; Keenan and 
Patton 1995; McManaman ct al. 1999). The prcscncc of 
XOR among MFGM proteins and its strong epithelial 
expression during lactation, provides strong supporting 
cvidcncc that the XOR+/- lactation phenotype is due to 
a dcfcct within the mammary epithelium and not for 
example, due to a systcmic dcfcct of lactogcnic hor­
mones. Hormonal dcfccts arc also unlikely in the 
XOR+/- micc, sincc reproduction occurs normally.
But what is the function of XOR during milk fat drop­
let sccrction? The role XOR plays in fat droplet envelop­
ing is unlikely to involve purine catabolism for several 
reasons: (1) Although XOR expression and cnzymatic ac­
tivity arc greatly increased during late pregnancy and 
throughout lactation, uric acid, the end product of purine 
catabolism, is found only at low levels in the mammary 
gland; (2) whereas the dehydrogenase form (XD) of XOR 
is predominantly responsible for purine catabolism in all 
cells, it is the oxidase form (XO) of XOR that associates 
with MFGM and also predominates in milk. Studies 
have shown that milk XO has a very low activity to­
wards purines, again indicating that the mammary-spe­
cific role of XOR is distinct from purine catabolism (Ku- 
rosaki ct al. 1996). Interestingly, the MFGM itself is 
competent to inducc the transition from the XD to the 
XO form, and this may be the important signal for the 
initiation of fat droplet enveloping and sccrction (Mc-
Xanthine oxidoreductase is necessary for lactation
Manaman ct al. 1999). A study comparing bovine milk 
XD and XO crystal structures suggests that the revers­
ible transformation of XD to XO is associated with a 
conformational changc of the molecule due to formation 
of disulfide bonds (Enroth ct al. 2000).
Our study suggests that XOR has a function in the 
mammary gland distinct from its catabolic function(s), 
and moreover that this function may be entirely struc­
tural and noncnzymatic. This hypothesis is further sup­
ported by the observed severity of the phenotype associ­
ated with the haploinsufficicncy of XOR. The time 
coursc for the loss of lactation and of fat droplet sccrc­
tion is consistent with progressive exhaustion of a mem- 
branc-associatcd structural component, rather than a re­
duction by 50% of an cnzymatic activity.
The catalytic activity of XOR depends on the molyb­
denum cofactor and the experimental incorporation of 
tungsten as a competitive antagonist of molybdenum 
yields enzymatically inactive XOR in various animal 
systems. Feeding rats on a tungstcn-supplcmcntcd mo­
lybdenum-free diet results in synthesis of inactive XOR 
and rcduccs liver XOR cnzymatic activity to less than 
10% of initial values. However, although XOR cnzymat­
ic activity is presumably also rcduccd in their mammary 
glands, neither the delivery of normal litters nor the 
growth of pups is affcctcd in tungstcn-trcatcd mothers. 
Liver XOR activity is undctcctablc in those pups while 
nursed by tungstcn-trcatcd mothers, but rises dramati­
cally after weaning, sincc the administration of molyb­
denum rapidly reconstitutes the cnzymatic activity of 
XOR. These studies suggest that the pups rcccivc tung­
sten and inactive dc-molybdo XOR through milk, yet it 
had no impact on the maternal mammary glands (Cohen 
ct al. 1974; Johnson ct al. 1974). Feeding tungsten to 
lactating goats and cows also shows a strong dccrcasc of 
milk XOR cnzymatic activity in both eases without any 
influcncc on milk yield (Owen and Proudfoot 1968). In­
terestingly, milk contains by nature a mixture of activc 
and inactive (dc-molybdo) XOR (McGartoll ct al. 1970; 
Vcntom ct al. 1988). While the cnzymatic activity of 
milk XOR changcs over time, the level of XOR protein 
remains relatively constant (Brown ct al. 1994, 1995). 
Oral administration of sodium molybdatc to cows and 
goats increases only the molybdenum contcnt in milk, 
but docs not alter the activity of milk XOR and also docs 
not causc changcs in milk fat contcnt or milk yield (Ki- 
crmcir and Capellari 1958; Hart ct al. 1967). Further­
more, in vitro experiments have shown that application 
of the XOR cnzymatic inhibitor allopurinol docs not af­
fect terminal differentiation of mammary cells (Hayden 
ct al. 1991). All the above results arc consistent with a 
noncnzymatic role for XOR protein in milk fat droplet 
sccrction.
TEM analysis of isolated MFGM reveals the cxistcncc 
of an intervening coat material between the inner facc of 
the MFGM bilaycr and the outer facc of the fat droplet 
monolayer. The coat material is a protein layer com­
posed of plasma membrane proteins associated with se­
lected cytosolic proteins, as well as proteins from the 
surfacc of the cytoplasmic lipid droplets. XOR and bu-
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tyrophilin (BTN) have been identified as the major pro­
teins forming this coat material (Franke et al. 1981). 
BTN, a member of the Ig superfamily, is a type I mem­
brane glycoprotein unique to the mammary gland, and 
the most abundant protein of bovine and guinea pig 
MFGM. Interestingly, coimmunoprecipitation studies 
with the cytoplasmatic domain of BTN suggest specific 
binding to XOR, and correlate with previous findings 
that XOR is tightly associated with the cytoplasmic sur­
face of the apical epithelial membrane (Ishii et al. 1995; 
Keenan and Patton 1995). BTN can also be covalently 
bound to XOR by bifunctional cross-linking agents 
(Valivullah and Keenan 1989). The aggregation of a BTN/ 
XOR complex may subsequently trigger the binding of 
additional molecules to form the protein corc. The major 
fat droplet surfacc protein, likely to be involved in pro­
tein corc formation during envelopment, is the adipocytc 
differentiation-related protein (ADRP). ADRP is fre­
quently associated with the surfacc of cytoplasmic lipid 
droplets, and together with XOR and BTN is a major 
component of the protein corc (Heid et al. 1996). Immu­
nohistochemical analysis of early lactating mammary 
tissue, as well as of milk from wild-type and XOR+/- 
mice, revealed no differences in the expression of ADRP 
and MUC-1, a MFGM protein of the mammary epithe­
lium (data not shown). It has been reported that BTN and 
XOR are expressed in constant molar proportions in bo­
vine MFGM and these proportions vary with breed and 
stage of lactation. Particularly, XOR as a homodimer 
may simultaneously bind two BTN molecules and there­
fore be responsible for the observed accumulation of 
BTN molecules on budding membrane areas (Mather et 
al. 2001). A likely explanation for the up-regulation of 
XOR during lactation is the high cellular demand for this 
structural molecule, since it is continuously lost from 
the ccll with cach budding fat droplet. The TEM analyses 
in Figures 5 and 6 show partially enveloped fat droplets 
in XOR+/- mammary glands. An attractive hypothesis is 
that only the membrane with enough localized XOR pro­
tein can successfully envelop a milk fat droplet. Other 
areas with less or no XOR may be cither missing the 
apical membrane or are enveloped by cytoplasmic cres­
cents of various lengths.
Our current model for the role of XOR in milk fat 
droplet enveloping is as follows: after parturition, the 
MFGM converts a significant amount of XOR from the 
XD to the XO form. This conformational change may 
allow XO to then interact with the cytoplasmic portion 
of BTN from the apical plasma membrane, leading to an 
accumulation of BTN at future membrane budding ar­
eas. BTN and XO may interact dircctly or indirectly with 
surfacc proteins from the CLDs, presumably ADRP. Ad­
ditional cytosolic proteins, proteins from the surfacc of 
CLDs, and proteins from the apical membrane may in­
teract with BTN, XO, and ADRP to form an entire pro­
tein corc between the apical membrane and the surfacc 
of the CLDs. The formation of the protein corc presum­
ably triggers the binding of the apical membrane to the 
CLD, resulting in tight enveloping and subsequent bud­
ding of the milk fat droplets from the mammary epithe­
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lial cclls (Heid et al. 1996, 1998; Mather and Keenan 
1998; McManaman ct al. 1999). Since XOR molecules 
are constantly lost from the lactating mammary epithe­
lium and are therefore in high demand, the reduction in 
the amount of XOR protein in XOR+/- mice leads to 
numerous defects in milk fat droplet enveloping, the de­
struction of the mammary epithelium, and premature in­
volution of the mammary gland.
In the context of evolution, wc suggest that the house­
keeping enzyme XOR became one of the key (structural) 
proteins that allow fat droplets to be secrcted and 
thereby creating a new ccll function in a new ccll type of 
the class mammalia. XOR is not the only housekeeping 
gene that performs an additional role in evolution. Stud­
ies on vertebrate and invertebrate lens proteins show 
that several metabolic housekeeping genes have been re­
cruited as taxon-specific structural lens proteins (crystal- 
lins), the major proteins in rcfractivc eye lenses. This 
phenomenon, the use of a gene and its encoded protein 
for more than one function, has been termed "gene shar­
ing" (Wistow and Piatigorsky 1987; Piatigorsky and 
Wistow 1989). While some of the crystallin proteins re­
tain full enzymatic activity, others have rcduccd or un­
known enzymatic activity (Ziglcr and Rao 1991). Just as 
for XOR in milk fat droplet secretion, the enzymatic 
activity of crystallin proteins may not be required for the 
additional structural role in the lens. Gene sharing of 
XOR in the lactating mammary gland, an evolutionarily 
young organ, provides a striking example of a gene ac­
quiring multiple functions during its evolution. How the 
additional role of XOR in milk fat droplet secretion and 
its presence in milk may have impinged on the evolu­
tionary development of the mammary gland will be ad­
dressed in a separate communication (C. Vorbach and 
M.R. Capccchi, in prep.).
As mentioned above, humans with mutations in XOR 
suffer from xanthinuria,- however, lactation problems 
have not been reported in these patients. This is particu­
larly striking, since already a heterozygous mutation of 
XOR in mouse causcs the destruction of the lactating 
mammary epithelium, mortally affecting the ability to 
nurse. A potential explanation for this difference be­
tween mice and humans is that mice have a milk fat 
content of 20%-30%, whereas human milk contains 
only about 4% fat. This suggests that a mutation in the 
XOR gene and a defect in milk fat droplet secretion may 
have a much stronger impact on the lactating murine 
mammary gland than on human lactation. Furthermore, 
the nature of the mutation (point mutations, deletions) 
should differentially affect the functionality of XOR in 
the mammary gland. Still, about 5% of women experi­
ence primary lactation insufficiency (Ncifert 2001), and 
XOR is a potential candidate gene for contributing to 
this deficiency.
In summary, wc have shown that mice heterozygous 
for a loss-of-function mutation in XOR arc unable to 
maintain lactation. The disruption of lactation is causcd 
by a XOR-dependent dcfect in the enveloping of milk fat 
droplets with the apical mammary epithelial membrane, 
thereby markedly interfering with secretion of those
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droplets into the milk, causing tissue necrosis and in­
duction of premature involution of the mammary gland.
Materials and methods
Cloning of a targeting vector for xanthine oxidoreduetase
XOR was cloned from a 129SvJ Lambda Fix II genomic library 
(Stratagene). Based on the published XOR cDNA sequence 
(Terao et al. 1992), synthetic oligonucleotide probes homolo­
gous to regions of exons 3 and 5, were used in the library screen 
ensuring that the recovered clones contained the most proximal 
redox active center of XOR. The oligonucleotide probe for exon 
3 had the sequence: 5'-TGTGCGGGACCAAGCTTGGCTGTG 
GAGAAGGTGGCT-3'. The oligonucleotide probe for exon 5 
had the sequence 5'-CATTCTCGATCTCCTCGACAGTAGG 
CTCAGGCTTGTTTCGGAG-3'. An 8.8-kb EcoRI fragment, 
surrounding exon 3, was isolated from the genomic library and 
used as the homologous region in the targeting vector. A re­
placement vector was generated by inserting a GFP/loxP/tACE- 
Cre /neo1 /loxP cassette at a unique Hindlll site in exon 3 
(Bunting et al. 1999). The linearized targeting vector was elec­
troporated into RI ES cells (Nagy et al. 1993) and ES cells en­
riched for the targeting event were selected with the drugs G418 
and FIAU. These ES cells were screened for accurate gene tar­
geting via Southern blot analysis. Correctly targeted ES clones 
were injected into C57BL/6J-derived blastocysts and then trans­
ferred to uteri of pseudopregnant mice. Chimeric males esti­
mated to contain >80% ES cell contribution were mated with 
BL6 females to obtain germline transmission at the mutant 
XOR allele (A.J. Scriven and M.R. Capecchi, in prep.).
Body weight analysis and dissection of pups
Each of six litters (three from wild-type and three from XOR+I- 
mothers) was reduced to the same size of six pups and the body 
weight increase was documented for each pup from lactation 
day 1 to 13. The average body weight of the wild-type and 
XOR+/- litter (n = 18) was calculated as means ± S.D. for each 
lactation day. Pups were euthanized with CO?, dissected, and 
analyzed macro- and microscopically.
Histology
Mammary glands #4 were removed from wild-type and XOR+I- 
mice, immediately cut into four pieces, and fixed in 4% Para­
formaldehyde/PBS overnight. The fixed glands were washed for 
3 x 10 min in PBS and paraffin embedded (Paraplast X-tra, CMS) 
with the help of a Modular Vacuum Processor (Instrumentation 
Laboratory) and a Tissue Embedding Center (Reichert-Jung) ac­
cording to standard methods. Six-micrometer tissue sections 
were mounted on pretreated glass slides (Superfrost Plus Micro 
Slides, VWR), mounted with D.P.X. (Aldrich) and observed us­
ing a Leitz Ortholux II with a 3CCD digital color camera 
(DAGE-MTI).
Whole-mount analysis
Mammary glands #3 were removed from wild-type and XOR+I- 
mice at different lactation days and immediately spread onto 
glass slides. After drying the glands to the slides for about 1 min, 
the glands were fixed in Carnoy's fixative (3 vol 100% EtOH, 1 
vol glacial acetic acid) overnight. The glands were washed in 
70% EtOH for 20 min, rinsed in water, and stained with car­
mine alum stain (2.5 g alum potassium sulfate, 1 g indigo car-
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mine, 500 mL water) overnight, washed in water, dehydrated, 
and mounted.
Semithin sections and electron microscopy
Mammary glands #4 were removed from wild-type and XOR+I- 
mice, cut in very small pieces, and fixed overnight (phosphate 
buffer at pH 7.4 containing 2% glutaraldehyde and 1 % para­
formaldehyde). The tissue was postfixed in 2% osmium tetrox­
ide buffered with phosphate buffer at pH 7.4 for 2-4 h, dehy­
drated and embedded with the EMbed 812 Kit (Electron Micros­
copy Sciences). Blocks were randomly sectioned (lpm-thick) 
and stained with 1 % toluidine blue/1 % sodium borate in water 
for light microscopy analysis (Leitz Ortholux II with a 3CCD 
digital color camera, DAGE-MTI). For electron microscopy, ran­
dom areas of mammary glands were thin sectioned with the aid 
of a diamond knife mounted on an ultramicrotome (LKB Nova; 
Leica). The thin sections (60-80 nm) were counterstained with 
uranyl acetate and lead citrate before the ultrastructural 
samples were observed, using a transmission electron micro­
scope (Hitachi H-7100, University of Utah, Research Micros­
copy Facility).
Enzymatic activity
Mammary glands #4 from wild-type and XOR+I- mice were 
collected and shock frozen with liquid nitrogen. Enzymatic 
analysis was performed according to (Beckman et al. 1989) with 
minor modifications. The tissue was homogenized in 2 mL of 50 
mM potassium phosphate at pH 7.4/0.1 mM EDTA and protease 
inhibitor (Complete, Roche) followed by sonication. The cell 
lysates were centrifuged at 18,000 g for 30 min at 4°C. Of the 
supernatant, 100 pL was diluted to 2 mL with 50 mM potassium 
phosphate/0.1 mM EDTA. Fluorescence was monitored at 390 
nm with the excitation wavelength set at 345 nm. After achiev­
ing a stable baseline, 20 pL of ImM pterin and 20 pL of ImM 
methylene blue were added as an electron acceptor to assay 
total XOR activity for 2 min. To inhibit and to confirm the 
specificity of the reaction, 20 pL (2 mM) allopurinol was added 
and the XOR activity reached a plateau. 20 pL (1 pM) isoxan­
thopterin was added as an internal standard after its exact con­
centration was determined spectrally (E336 = 13.0 mM 7cm J). 
XOR activity was expressed as micromolar of isoxanthopterin 
formed/minutes per milligram protein. The total protein con­
centrations in the above-described supernatants were deter­
mined by dye-binding assay (Bio-Rad Laboratories) according to 
manufacturer's instructions.
Milk analysis
Pups were removed for 2-5 h before milking the mothers. Mice 
were anesthetized with avertin (450 pL/25 g body weight) and 
injected intraperitoneally with Oxytoxin (0.3 IU; Sigma) in 200 
pL PBS. After a 5-10-min incubation period milk was with­
drawn with a Pasteur pipette attached to tubing and a mouth­
piece. For creamatocrit analysis, an estimation of total milk 
lipid content, 10 wild-type and 10 XOR+I- mice were milked on 
lactation day 2. The milk was spun in a haematocrit centrifuge 
and the fat content was estimated using Spiracrit, a micro-he­
matocrit capillary tube reader (Lancer; Lucas et al. 1978). For 
milk protein analysis, three wild-type and three XOR+I- mice 
were milked on 5 consecutive days and 0.5 pL milk was ana­
lyzed with SDS-PAGE using a 15% resolving and a 5% stacking 
gel.
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